IMMUNOBANK Trademark

Trademark Overview

On Thursday, November 5, 2020, a trademark application was filed for IMMUNOBANK with the United States Patent and Trademark Office. The USPTO has given the IMMUNOBANK trademark a serial number of 90301291. The federal status of this trademark filing is REGISTERED as of Tuesday, June 21, 2022. This trademark is owned by Atherovax Inc.. The IMMUNOBANK trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Isolation, collection, and banking of biological samples from healthy donors and patients with immune diseases, including, but not limited to, allergies, infections, autoimmune diseases, cancer, and atherosclerosis
immunobank

General Information

Serial Number90301291
Word MarkIMMUNOBANK
Filing DateThursday, November 5, 2020
Status700 - REGISTERED
Status DateTuesday, June 21, 2022
Registration Number6769074
Registration DateTuesday, June 21, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 10, 2021

Trademark Statements

Pseudo MarkIMMUNO BANK
Goods and ServicesIsolation, collection, and banking of biological samples from healthy donors and patients with immune diseases, including, but not limited to, allergies, infections, autoimmune diseases, cancer, and atherosclerosis

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 6, 2021
Primary Code044
First Use Anywhere DateTuesday, November 30, 2021
First Use In Commerce DateTuesday, November 30, 2021

Trademark Owner History

Party NameAtherovax Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameAtherovax Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameAtherovax Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Tuesday, June 21, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 21, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, May 19, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 18, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 21, 2022ASSIGNED TO LIE
Wednesday, April 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 21, 2022NON-FINAL ACTION E-MAILED
Friday, January 21, 2022SU - NON-FINAL ACTION - WRITTEN
Sunday, December 26, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 1, 2021USE AMENDMENT FILED
Sunday, December 26, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 1, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, October 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 10, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 10, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 1, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, July 1, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 1, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, July 1, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, July 1, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, June 22, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, June 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 24, 2021EXAMINER'S AMENDMENT ENTERED
Monday, May 24, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 24, 2021EXAMINERS AMENDMENT E-MAILED
Monday, May 24, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, April 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 19, 2021NON-FINAL ACTION E-MAILED
Monday, April 19, 2021NON-FINAL ACTION WRITTEN
Monday, April 12, 2021ASSIGNED TO EXAMINER
Wednesday, January 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

immunobank diseases limited including allergies infections atherosclerosis cancer autoimmune immune patients